Today, the Changsha Economic and Technological Development Zone announced the list of enterprises to receive the 2024 Special Industrial Development Policy Funds. YuanPin Biotechnology has successfully been selected for funding, thanks to its outstanding achievements in building an innovative platform.

 

As a leading enterprise in the field of stem cells and regenerative medicine in China, YuanPin Biotechnology remains committed to its mission of "advancing human health." The company continues to expand its presence across the entire cell industry chain. Its investment in the construction of the Central South YuanPin Stem Cell Technology Park is a major milestone in that effort.